JULIE BAINBRIDGE: Open Payments
NPI 1073237210 · SALIDA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $996 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $160 |
| Tris Pharma Inc | 1 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Lundbeck LLC | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Alkermes, Inc. | 2 | $52 |
| Corium, LLC | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Indivior Inc. | 1 | $20 |
Products named: FANAPT, REXULTI, Dyanavel XR, COBENFY, CAPLYTA, ARISTADA, Azstarys, Auvelity.
Industry payments across CO — which companies pay providers there.
